After lots of tests, it looks like a big step forward in fighting obesity
Insurance accepted.
Many GLP-1s are FDA approved for more than just weight loss, including type 2 diabetes, cardiovascular risk reduction, and even stroke prevention in certain populations, says Supriya Rao, MD, an obesity physician and the director of medical weight loss at Lowell General Hospital in Lowell, Massachusetts
Ethics declarations Competing interests DJC has received investigator-initiated grants from Astra Zeneca and Novo Nordisk, as well as speaker fees for lectures
Clinical studies show equivalent efficacy and tolerability, with additional advantages of flexible dosing, lower cost, and faster access without insurance delays
Melanotan 2 is highly effective in achieving safe, high quality and long-lasting tan